Shots:
The EMA’s CHMP has granted positive opinions and approvals to 2 Biologics and 1 New Chemical Entity in March 2025, leading to treatments for patients and advances in the healthcare industry
The major highlighted drugs were Merck’s Capvaxive to treat invasive pneumococcal disease
PharmaShots has compiled a list of 3 drugs that have been…
